Funding for this research was provided by:
National Natural Science Foundation of China (81800344, 81800345, and 82000372)
Natural Science Foundation of Guangdong Province (2022A1515111120, 2020A1515010452 and 2020A1515011095)
Received: 18 September 2022
Accepted: 16 March 2023
First Online: 29 March 2023
: All subjects in the Framingham Heart Study had signed informed consent forms. Our current study was approved by the Medical Ethical Committee of the First Affiliated Hospital, Sun Yat-sen University (Application ID: 266).
: Not applicable.
: The authors declare that they have no competing interests.